Table 1 Patient Characteristics
Pt | Age | NET Type | Sites of SSTR-Positive Disease | Rx | Dose | Vol 1 | Vol 2 | CG1 | CG2 |
|---|---|---|---|---|---|---|---|---|---|
1 | 40 | SB Carcinoid | Nodes | 12 | 30 S | 3.22 | 5.1 | < 1.6 | < 1.6 |
2 | 61 | Pancreatic | Pancreas, Lungs | 8 | 30 S | 4.3 | 11 | 51 | 16 |
3 | 55 | SB Carcinoid | Small Bowel, Nodes, Peritoneal | 6 | 30 S | 6.1 | 5.1 | 62 | 32 |
4 | 53 | SB Carcinoid | Liver, Peritoneum, Nodes | 12 | 30 S | 7.9 | 10.6 | 345 | 175 |
5 | 62 | SB Carcinoid | Nodes | 3 | 120 L | 9.5 | 9.8 | 40 | 23 |
6 | 41 | Bronchial | Lungs, Bones, Salivary Glands | 6 | 30 S | 12.5 | 12.8 | 9.3 | < 6 |
7 | 52 | SB Carcinoid | Breasts, Nodes, Liver, Peritoneal | 4 | 30 S | 13.6 | 14.6 | NA | NA |
8 | 39 | SB Carcinoid | Bone, Liver | 6 | 30 S | 14.8 | 15.2 | NA | NA |
9 | 56 | SB Carcinoid | Liver, Peritoneal, Ovary | 5 | 30 S | 19.2 | 19.8 | 35 | 14 |
10 | 89 | SB Carcinoid | Small bowel, Nodes, Peritoneal | 4 | 90 L | 29.4 | 27.6 | 265 | 48 |
11 | 55 | SB Carcinoid | Peritoneal, Nodes, Liver | 5 | 30 S | 51.8 | 46.7 | 99 | 101 |
12 | 66 | SB Carcinoid | Small Bowel, Peritoneal | 4 | 30 S | 67.2 | 62.4 | 454 | 111 |
13 | 80 | Pancreatic | Pancreas, Liver | 6 | 30 S | 1.4 | 100 | 77 | 243 |
14 | 49 | SB Carcinoid | Liver, Bones, Peritoneum | 6 | 40 S | 3 | 46.4 | 82 | 212 |
15 | 30 | Pancreatic | Liver | 13 | 30 S | 7.8 | 45 | 79 | 640 |
16 | 66 | Paraganglioma | Pelvic / Peri-hepatic masses, Bone | 3 | 20 S | 38.6 | 75.1 | 14 | 26 |
17 | 73 | SB Carcinoid | Ileum, Nodes, Liver | 5 | 30 S | 44.1 | 201.2 | 267 | NA |
18 | 65 | Bronchial | Bone, Liver | 10 | 30 S | 45.2 | 120.5 | < 121 | 130 |
19 | 68 | SB Carcinoid | Liver, Nodes | 6 | 30 S | 86.7 | 472.3 | 144 | 750 |
20 | 67 | SB Carcinoid | Liver, Bones | 2 | 30 S | 205.3 | 297.6 | NA | NA |
21 | 65 | Pancreatic | Pancreas, Liver | 6 | 20 S | 338 | 783 | 129 | 133 |